The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 07, 2026
Filed:
Oct. 05, 2022
Applicant:
Iceutica Pty Ltd., Iluka, AU;
Inventors:
Aaron Dodd, Centennial Park, AU;
H William Bosch, Bryn Mawr, PA (US);
Felix Meiser, Mount Claremont, AU;
Marck Norret, Darlington, AU;
Adrian Russell, Rivervale, AU;
Assignee:
iCeutica Pty Ltd., Iluka, AU;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/16 (2006.01); A01N 25/10 (2006.01); A01N 25/12 (2006.01); A01N 25/34 (2006.01); A01N 37/38 (2006.01); A01N 47/36 (2006.01); A01N 55/02 (2006.01); A01N 57/20 (2006.01); A23L 33/10 (2016.01); A23P 10/20 (2016.01); A23P 10/30 (2016.01); A61J 3/02 (2006.01); A61K 9/00 (2006.01); A61K 9/14 (2006.01); A61K 31/122 (2006.01); A61K 31/137 (2006.01); A61K 31/18 (2006.01); A61K 31/192 (2006.01); A61K 31/196 (2006.01); A61K 31/198 (2006.01); A61K 31/404 (2006.01); A61K 31/405 (2006.01); A61K 31/415 (2006.01); A61K 31/421 (2006.01); A61K 31/4709 (2006.01); A61K 31/496 (2006.01); A61K 31/497 (2006.01); A61K 31/53 (2006.01); A61K 31/5415 (2006.01); A61K 31/565 (2006.01); A61K 31/57 (2006.01); A61K 33/04 (2006.01); A61K 38/13 (2006.01); B02C 17/20 (2006.01); B02C 19/00 (2006.01);
U.S. Cl.
CPC ...
A61K 9/1682 (2013.01); A01N 25/10 (2013.01); A01N 25/12 (2013.01); A01N 25/34 (2013.01); A01N 37/38 (2013.01); A01N 47/36 (2013.01); A01N 55/02 (2013.01); A01N 57/20 (2013.01); A23L 33/10 (2016.08); A23P 10/20 (2016.08); A23P 10/30 (2016.08); A61J 3/02 (2013.01); A61K 9/0075 (2013.01); A61K 9/145 (2013.01); A61K 9/146 (2013.01); A61K 9/1617 (2013.01); A61K 9/1623 (2013.01); A61K 9/1635 (2013.01); A61K 9/1652 (2013.01); A61K 31/122 (2013.01); A61K 31/137 (2013.01); A61K 31/18 (2013.01); A61K 31/192 (2013.01); A61K 31/196 (2013.01); A61K 31/198 (2013.01); A61K 31/404 (2013.01); A61K 31/405 (2013.01); A61K 31/415 (2013.01); A61K 31/421 (2013.01); A61K 31/4709 (2013.01); A61K 31/496 (2013.01); A61K 31/497 (2013.01); A61K 31/53 (2013.01); A61K 31/5415 (2013.01); A61K 31/565 (2013.01); A61K 31/57 (2013.01); A61K 33/04 (2013.01); A61K 38/13 (2013.01); B02C 17/20 (2013.01); B02C 19/0056 (2013.01); A23V 2002/00 (2013.01);
Abstract
A method for using dry milling to prepare nanoparticle and microparticle powders of a biologically active material are described. The nanoparticle and microparticle powders have desirable powder handling characteristics such as good content uniformity that make them suitable for commercial manufacture of drug products.